Annette Ljungmark

This profile gathers the share dealings of Annette Ljungmark in Oasmia Pharmaceutical AB. The record holds 4 filings, for trades running from 7 September 2016 to 24 July 2017.

Purchases make up the whole of the open-market record (3 purchases, €16k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2017: 2 purchases and no sales on the market.

In size, the median ticket on the buying side is €5,261. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 25 July 2017 with an open-market purchase (€4,391) in Oasmia Pharmaceutical AB. Filings reach the Finansinspektionen feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.